Jihye Hong

1.4k total citations · 1 hit paper
20 papers, 1.1k citations indexed

About

Jihye Hong is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Jihye Hong has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 8 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Jihye Hong's work include CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (7 papers) and Immune Cell Function and Interaction (4 papers). Jihye Hong is often cited by papers focused on CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (7 papers) and Immune Cell Function and Interaction (4 papers). Jihye Hong collaborates with scholars based in South Korea, Sudan and Puerto Rico. Jihye Hong's co-authors include Byung‐Soo Kim, Mikyung Kang, Mungyo Jung, Seuk Young Song, Seokhyeong Go, Sung Pil Kwon, Han Young Kim, Yeon Woong Choo, Ju‐Ro Lee and Jin Han and has published in prestigious journals such as Advanced Materials, Nature Communications and Nano Letters.

In The Last Decade

Jihye Hong

20 papers receiving 1.1k citations

Hit Papers

M1 Macrophage-Derived Nanovesicles Potentiate the Antican... 2018 2026 2020 2023 2018 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jihye Hong South Korea 14 536 507 465 237 147 20 1.1k
Mungyo Jung South Korea 14 510 1.0× 483 1.0× 398 0.9× 231 1.0× 126 0.9× 20 1.1k
Seokhyeong Go South Korea 10 392 0.7× 367 0.7× 310 0.7× 180 0.8× 87 0.6× 12 767
Padma Kadiyala United States 15 446 0.8× 425 0.8× 269 0.6× 303 1.3× 188 1.3× 41 1.1k
Darya Alizadeh United States 15 327 0.6× 757 1.5× 320 0.7× 501 2.1× 149 1.0× 23 1.3k
Esra Güç United States 10 470 0.9× 277 0.5× 184 0.4× 388 1.6× 74 0.5× 17 1.0k
Sharon Wei Ling Lee Singapore 9 360 0.7× 178 0.4× 272 0.6× 240 1.0× 77 0.5× 13 815
Qingle Liang China 9 442 0.8× 235 0.5× 263 0.6× 137 0.6× 125 0.9× 19 911
Jingshu Meng China 13 444 0.8× 244 0.5× 161 0.3× 238 1.0× 52 0.4× 17 833

Countries citing papers authored by Jihye Hong

Since Specialization
Citations

This map shows the geographic impact of Jihye Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jihye Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jihye Hong more than expected).

Fields of papers citing papers by Jihye Hong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jihye Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jihye Hong. The network helps show where Jihye Hong may publish in the future.

Co-authorship network of co-authors of Jihye Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Jihye Hong. A scholar is included among the top collaborators of Jihye Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jihye Hong. Jihye Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Cheesue, Hyeok Kim, Woo‐Sup Sim, et al.. (2024). Spatiotemporal control of neutrophil fate to tune inflammation and repair for myocardial infarction therapy. Nature Communications. 15(1). 8481–8481. 20 indexed citations
2.
Jung, Mungyo, Seokhyeong Go, Jihye Hong, et al.. (2024). Engineered Nanoparticles for Enhanced Antitumoral Synergy Between Macrophages and T Cells in the Tumor Microenvironment. Advanced Materials. 36(44). e2410340–e2410340. 10 indexed citations
3.
Hong, Jihye, Suyoung Lee, Choong‐Hyun Koh, et al.. (2023). A Personalized Cancer Vaccine that Induces Synergistic Innate and Adaptive Immune Responses. Advanced Materials. 35(36). e2303080–e2303080. 12 indexed citations
4.
Hong, Jihye, Mungyo Jung, Cheesue Kim, et al.. (2023). Senescent cancer cell-derived nanovesicle as a personalized therapeutic cancer vaccine. Experimental & Molecular Medicine. 55(3). 541–554. 21 indexed citations
5.
Moon, Sangjun, Jihye Hong, Seokhyeong Go, & Byung‐Soo Kim. (2023). Immunomodulation for Tissue Repair and Regeneration. Tissue Engineering and Regenerative Medicine. 20(3). 389–409. 25 indexed citations
6.
Go, Seokhyeong, Mungyo Jung, Suyoung Lee, et al.. (2023). A Personalized Cancer Nanovaccine that Enhances T‐Cell Responses and Efficacy Through Dual Interactions with Dendritic Cells and T Cells. Advanced Materials. 35(49). e2303979–e2303979. 27 indexed citations
7.
Jung, Mungyo, Jung Won Hwang, Mikyung Kang, et al.. (2023). Iron Oxide Nanoparticle-Incorporated Mesenchymal Stem Cells for Alzheimer’s Disease Treatment. Nano Letters. 23(2). 476–490. 20 indexed citations
8.
Jung, Mungyo, Jihye Hong, Cheesue Kim, et al.. (2022). A Therapeutic Nanovaccine that Generates Anti‐Amyloid Antibodies and Amyloid‐specific Regulatory T Cells for Alzheimer's Disease. Advanced Materials. 35(3). e2207719–e2207719. 35 indexed citations
9.
Kim, Cheesue, Songhyun Lim, Mungyo Jung, et al.. (2022). A Senolytic-Eluting Coronary Stent for the Prevention of In-Stent Restenosis. ACS Biomaterials Science & Engineering. 8(5). 1921–1929. 9 indexed citations
10.
Jung, Mungyo, Mikyung Kang, Jihye Hong, et al.. (2021). Nanovesicle‐Mediated Targeted Delivery of Immune Checkpoint Blockades to Potentiate Therapeutic Efficacy and Prevent Side Effects. Advanced Materials. 34(9). e2106516–e2106516. 50 indexed citations
11.
Kang, Mikyung, Seong Ho Lee, Junho Byun, et al.. (2021). Nanocomplex‐Mediated In Vivo Programming to Chimeric Antigen Receptor‐M1 Macrophages for Cancer Therapy. Advanced Materials. 33(43). e2103258–e2103258. 154 indexed citations
12.
Kwon, Sung Pil, Seuk Young Song, Jin Yoo, et al.. (2021). Multilayered Cell Sheets of Cardiac Reprogrammed Cells for the Evaluation of Drug Cytotoxicity. Tissue Engineering and Regenerative Medicine. 18(5). 807–818. 5 indexed citations
13.
Lee, Jae Geun, Kyung‐Cheol Sohn, Kayoung Lee, et al.. (2021). IQ-Switch is a QF-based innocuous, silencing-free, and inducible gene switch system in zebrafish. Communications Biology. 4(1). 1405–1405. 5 indexed citations
14.
Hong, Jihye, Mikyung Kang, Mungyo Jung, et al.. (2021). T‐Cell‐Derived Nanovesicles for Cancer Immunotherapy. Advanced Materials. 33(33). e2101110–e2101110. 61 indexed citations
15.
Kang, Mikyung, Jihye Hong, Mungyo Jung, et al.. (2020). T‐Cell‐Mimicking Nanoparticles for Cancer Immunotherapy. Advanced Materials. 32(39). e2003368–e2003368. 103 indexed citations
16.
Song, Seuk Young, Jihye Hong, Songhyun Lim, et al.. (2020). Interleukin‐4 Gene Transfection and Spheroid Formation Potentiate Therapeutic Efficacy of Mesenchymal Stem Cells for Osteoarthritis. Advanced Healthcare Materials. 9(5). e1901612–e1901612. 38 indexed citations
17.
Song, Seuk Young, Jin Yoo, Seokhyeong Go, et al.. (2019). Cardiac-mimetic cell-culture system for direct cardiac reprogramming. Theranostics. 9(23). 6734–6744. 17 indexed citations
18.
Kim, Han Young, Mikyung Kang, Yeon Woong Choo, et al.. (2019). Immunomodulatory Lipocomplex Functionalized with Photosensitizer-Embedded Cancer Cell Membrane Inhibits Tumor Growth and Metastasis. Nano Letters. 19(8). 5185–5193. 84 indexed citations
19.
Hong, Jihye & Byung‐Soo Kim. (2018). Regulatory T Cell-Mediated Tissue Repair. Advances in experimental medicine and biology. 1064. 221–233. 12 indexed citations
20.
Choo, Yeon Woong, Mikyung Kang, Han Young Kim, et al.. (2018). M1 Macrophage-Derived Nanovesicles Potentiate the Anticancer Efficacy of Immune Checkpoint Inhibitors. ACS Nano. 12(9). 8977–8993. 381 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026